Airdate: Tuesday, January 31, 2023 Season: 2 Episode: 1
Guest: Yelena Akelina
This episode of #ShareScience features Yelena Akelina, DVM, MS, a Research Scientist and the Co-Director/Instructor in Clinical Microsurgery at the Microsurgery Research and Training Lab at Columbia University. She has been educating microvascular surgeons and medical personnel from all over the US and abroad since 1996 and is passionate about teaching surgeons to perform surgery on very small (1mm diameter) vessels and nerves under the microscope to enable them to perform similar surgical procedures in the clinic, and ultimately save lives.
To learn more about the courses that Yelena teaches, click here.
To watch the interview and read the full blog, click here.
Similar Podcasts
Talking Real Science with Meaghan Loy on Rare Disease Day
On this episode of #ShareScience, we spoke with Meaghan Loy, Senior Category Director of In Vivo Services with Scientist.com, on Rare Disease Day.
#ExpertAnswers: Marcel Perret-Gentil on Improving Surgical Outcomes
Marcel Perret-Gentil presents six simple-to-implement techniques to significantly improve surgical outcomes, to lessen post-op mortality and improve data yield after surgery.
#ExpertAnswers: Phil Griffiths on Telemetry Studies
Phil Griffiths draws from his experience as a telemetry user to discuss some important considerations for designing telemetry studies.
Related Content
Unraveling European Animal Welfare Legislation for Biotech & Pharma
This event illuminates the intricacies of animal welfare legislation, specifically comparing and distinguishing differences between EU, UK, and North American standards.
Superpixel Unmixing Algorithm from Micro to Macro Photoacoustic Imaging of Tissue Components
Dr. Valeria Grasso describes a novel unsupervised Machine-Learning method named Superpixel Photoacoustic Unmixing (SPAX) framework.
Understanding Animal Welfare Best Practices in Asia Pacific for Biotech & Pharma
In this event, we focus on the Asia Pacific region, uncovering the landscape of animal welfare legislation and its implications for pharmaceutical and biotech players.